Home Cart Sign in  
Chemical Structure| 1271738-59-0 Chemical Structure| 1271738-59-0
Chemical Structure| 1271738-59-0

MI-3

CAS No.: 1271738-59-0

MI-3 is a Menin-MLL interaction inhibitor with IC50 value of 648 ± 25 nM.

Synonyms: Menin-MLL inhibitor 3; Menin-MLL Inhibitor

4.5 *For Research Use Only !

Cat. No.: A446224 Purity: 98%

Change View

Size Price

US Stock

Global Stock

In Stock
1mg łÿď¶ÊÊ Inquiry Inquiry
5mg łď§¶ÊÊ Inquiry Inquiry
10mg łîͶÊÊ Inquiry Inquiry
25mg łÇóó¶ÊÊ Inquiry Inquiry
50mg ł§Çó¶ÊÊ Inquiry Inquiry
100mg łÍóó¶ÊÊ Inquiry Inquiry
250mg łÇÊËͶÊÊ Inquiry Inquiry

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1mg

    łÿď¶ÊÊ

  • 5mg

    łď§¶ÊÊ

  • 10mg

    łîͶÊÊ

  • 25mg

    łÇóó¶ÊÊ

  • 50mg

    ł§Çó¶ÊÊ

  • 100mg

    łÍóó¶ÊÊ

  • 250mg

    łÇÊËͶÊÊ

In Stock

- +

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Alternative Products

Product Details of MI-3

CAS No. :1271738-59-0
Formula : C18H25N5S2
M.W : 375.55
SMILES Code : CC(C)C1=CC2=C(N3CCN(C4=NCC(C)(C)S4)CC3)N=CN=C2S1
Synonyms :
Menin-MLL inhibitor 3; Menin-MLL Inhibitor
MDL No. :MFCD28348362

Safety of MI-3

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Related Pathways of MI-3

epigenetics

Isoform Comparison

Biological Activity

Target
  • Histone Methyltransferase

    Menin-MLL, IC50:648 nM

In Vitro:

Cell Line
Concentration Treated Time Description Reference
MV4-11 cells 10.7–53.7 μM 24, 48, 72 hours Evaluate the inhibitory effect of PLX51107 on FLT3-ITD mutated AML cells PMC6781368
MOLM-13 cells 10.6–53.5 μM 24, 48, 72 hours To evaluate the effect of MI-3 on the viability of MLL-rearranged AML cells, showing that MI-3 significantly inhibited cell viability in a dose- and time-dependent manner. PMC6781368

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description Reference
Mice Prostate cancer xenograft model Intravenous injection 0.25 mg/kg Single dose, 15 min pretreatment To evaluate the protective effect of JHU-2545 on kidneys and salivary glands, results showed that JHU-2545 significantly reduced the uptake of PSMA radioligands in kidneys and salivary glands but had no significant effect on tumor uptake. PMC11928385
Nude mice MLL-rearranged AML xenograft model Oral gavage 40 mg/kg/day Once daily for 14 days To evaluate the anti-tumor activity of MI-3 in vivo against MLL-rearranged AML, showing that MI-3 significantly reduced tumor burden, reflected by decreased tumor volume and weight. PMC6781368

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.66mL

0.53mL

0.27mL

13.31mL

2.66mL

1.33mL

26.63mL

5.33mL

2.66mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories